You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

List of Excipients in API minocycline


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing minocycline

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Journey Medical Corporation AMZEEQ minocycline 69489-201 BUTANE
Journey Medical Corporation AMZEEQ minocycline 69489-201 CETOSTEARYL ALCOHOL
Journey Medical Corporation AMZEEQ minocycline 69489-201 COCONUT OIL
Journey Medical Corporation AMZEEQ minocycline 69489-201 CYCLOMETHICONE
Journey Medical Corporation AMZEEQ minocycline 69489-201 DOCOSANOL
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for minocycline

Excipient focus: ALCOHOL

Excipient focus: ALUMINUM OXIDE

Excipient focus: AMMONIA

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BUTANE

Excipient focus: BUTYL ALCOHOL

Excipient focus: CARNAUBA WAX

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CETOSTEARYL ALCOHOL

Excipient focus: COCONUT OIL

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: CROSPOVIDONE

Excipient focus: CYCLOMETHICONE

Excipient focus: D&C RED NO. 27

Excipient focus: D&C RED NO. 28

Excipient focus: D&C RED NO. 33

Excipient focus: D&C YELLOW NO. 10

minocycline drug variants containing D&C YELLOW NO. 10

Company Ingredient NDC
Amneal Pharmaceuticals of New York LLC minocycline hydrochloride 0115-9935
Actavis Pharma Inc minocycline hydrochloride 0591-5694
Sun Pharmaceutical Industries Inc minocycline hydrochloride 10631-330
Aphena Pharma Solutions - Tennessee LLC minocycline hydrochloride 43353-105
Aphena Pharma Solutions - Tennessee LLC minocycline hydrochloride 43353-172
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: DOCOSANOL

Excipient focus: ETHYLCELLULOSE

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C RED NO. 3

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 5

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: HYDROGENATED CASTOR OIL

Excipient focus: HYDROGENATED SOYBEAN OIL

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: ISOBUTANE

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LIGHT MINERAL OIL

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MAGNESIUM SULFATE

Excipient focus: MAGNESIUM SULFATE HEPTAHYDRATE

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

Excipient focus: MYRISTYL ALCOHOL

Excipient focus: NITROGEN

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 4000

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYSORBATE 80

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: POVIDONE

Excipient focus: POVIDONE K29/32

Excipient focus: POVIDONE K30

Excipient focus: POVIDONES

Excipient focus: PROPANE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: SOYBEAN OIL

Excipient focus: STARCH, CORN

Excipient focus: STEARIC ACID

Excipient focus: STEARYL ALCOHOL

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: TRIETHYL CITRATE

Excipient focus: WATER

Excipient focus: WHITE WAX

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group